{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:31:43Z","timestamp":1787311903204,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Projects in Guangzhou"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11064-026-04767-x","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:12:07Z","timestamp":1777907527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lamotrigine Improves Spatial Learning and Attenuates AD-Related Pathology in APP\/PS1 Mice, with Possible Involvement of the cAMP\/PKA\/CREB Pathway"],"prefix":"10.1007","volume":"51","author":[{"given":"Xiaoyu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"10","key":"4767_CR1","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2016","unstructured":"Xu L, He D, Bai Y (2016) Microglia-Mediated Inflammation and Neurodegenerative Disease. Mol Neurobiol 53(10):6709\u20136715","journal-title":"Mol Neurobiol"},{"key":"4767_CR2","doi-asserted-by":"publisher","first-page":"1456253","DOI":"10.3389\/fncel.2024.1456253","volume":"18","author":"I Fruholz","year":"2024","unstructured":"Fruholz I, Meyer-Luehmann M (2024) The intricate interplay between microglia and adult neurogenesis in Alzheimer\u2019s disease. Front Cell Neurosci 18:1456253","journal-title":"Front Cell Neurosci"},{"issue":"10284","key":"4767_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"1","key":"4767_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370","journal-title":"Eur J Neurol"},{"issue":"10","key":"4767_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.it.2015.08.008","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y et al (2015) Microglia: Dynamic Mediators of Synapse Development and Plasticity. Trends Immunol 36(10):605\u2013613","journal-title":"Trends Immunol"},{"issue":"4","key":"4767_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140(4):417\u2013447","journal-title":"Acta Neuropathol"},{"key":"4767_CR7","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fneur.2019.01266","volume":"10","author":"J Baker","year":"2019","unstructured":"Baker J et al (2019) A Longitudinal Study of Epileptic Seizures in Alzheimer\u2019s Disease. Front Neurol 10:1266","journal-title":"Front Neurol"},{"issue":"5","key":"4767_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC et al (2006) Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia 47(5):867\u2013872","journal-title":"Epilepsia"},{"issue":"4","key":"4767_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","volume":"66","author":"JJ Palop","year":"2009","unstructured":"Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66(4):435\u2013440","journal-title":"Arch Neurol"},{"issue":"3","key":"4767_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.neuron.2010.10.020","volume":"68","author":"JA Harris","year":"2010","unstructured":"Harris JA et al (2010) Transsynaptic progression of amyloid-\u03b2-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 68(3):428\u2013441","journal-title":"Neuron"},{"issue":"1\u20132","key":"4767_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eplepsyres.2011.01.003","volume":"94","author":"S Ziyatdinova","year":"2011","unstructured":"Ziyatdinova S et al (2011) Spontaneous epileptiform discharges in a mouse model of Alzheimer\u2019s disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Res 94(1\u20132):75\u201385","journal-title":"Epilepsy Res"},{"issue":"3","key":"4767_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L et al (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149(3):708\u2013721","journal-title":"Cell"},{"key":"4767_CR13","doi-asserted-by":"publisher","first-page":"1432002","DOI":"10.3389\/fncel.2024.1432002","volume":"18","author":"SSK Durairajan","year":"2024","unstructured":"Durairajan SSK et al (2024) Unraveling the interplay of kinesin-1, tau, and microtubules in neurodegeneration associated with Alzheimer\u2019s disease. Front Cell Neurosci 18:1432002","journal-title":"Front Cell Neurosci"},{"issue":"42","key":"4767_CR14","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE et al (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci U S A 109(42):E2895\u2013E2903","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4767_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650.2017.1370096","volume":"56","author":"B Alyahya","year":"2018","unstructured":"Alyahya B et al (2018) Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clin Toxicol (Phila) 56(2):81\u201389","journal-title":"Clin Toxicol (Phila)"},{"key":"4767_CR16","doi-asserted-by":"crossref","unstructured":"Costa B, Vale N (2023) Understanding Lamotrigine\u2019s Role in the CNS and Possible Future Evolution. Int J Mol Sci, 24(7)","DOI":"10.3390\/ijms24076050"},{"issue":"1","key":"4767_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3988\/jcn.2007.3.1.31","volume":"3","author":"JG Seo","year":"2007","unstructured":"Seo JG et al (2007) Comparison of cognitive effects of lamotrigine and oxcarbazepine in epilepsy patients. J Clin Neurol 3(1):31\u201337","journal-title":"J Clin Neurol"},{"issue":"2","key":"4767_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1212\/WNL.52.2.321","volume":"52","author":"R Martin","year":"1999","unstructured":"Martin R et al (1999) Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52(2):321\u2013327","journal-title":"Neurology"},{"issue":"2\u20133","key":"4767_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s007020050059","volume":"105","author":"S Tekin","year":"1998","unstructured":"Tekin S et al (1998) Antiglutamatergic therapy in Alzheimer\u2019s disease\u2013effects of lamotrigine. Short communication. J Neural Transm (Vienna) 105(2\u20133):295\u2013303","journal-title":"J Neural Transm (Vienna)"},{"key":"4767_CR20","doi-asserted-by":"publisher","first-page":"106106","DOI":"10.1016\/j.nbd.2023.106106","volume":"181","author":"E Rizzello","year":"2023","unstructured":"Rizzello E et al (2023) Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer\u2019s disease mouse model. Neurobiol Dis 181:106106","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4767_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/1673-5374.343888","volume":"18","author":"XX Fu","year":"2023","unstructured":"Fu XX et al (2023) Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer\u2019s disease. Neural Regen Res 18(1):189\u2013193","journal-title":"Neural Regen Res"},{"issue":"12","key":"4767_CR22","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.neurobiolaging.2014.06.009","volume":"35","author":"MY Zhang","year":"2014","unstructured":"Zhang MY et al (2014) Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP\/PS1 transgenic mice. Neurobiol Aging 35(12):2713\u20132725","journal-title":"Neurobiol Aging"},{"issue":"7","key":"4767_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1871527318666190807160137","volume":"18","author":"X Fu","year":"2019","unstructured":"Fu X et al (2019) Formononetin Ameliorates Cognitive Disorder via PGC-1alpha Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice. CNS Neurol Disord Drug Targets 18(7):566\u2013577","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"14","key":"4767_CR24","doi-asserted-by":"publisher","first-page":"14819","DOI":"10.18632\/aging.103544","volume":"12","author":"R Duan","year":"2020","unstructured":"Duan R et al (2020) ACE2 activator diminazene aceturate ameliorates Alzheimer\u2019s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice. Aging 12(14):14819\u201314829","journal-title":"Aging"},{"key":"4767_CR25","doi-asserted-by":"publisher","first-page":"p7810196","DOI":"10.1155\/2016\/7810196","volume":"2016","author":"K Wang","year":"2016","unstructured":"Wang K et al (2016) Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer\u2019s-Like Mouse Model. Biomed Res Int 2016:p7810196","journal-title":"Biomed Res Int"},{"key":"4767_CR26","doi-asserted-by":"publisher","first-page":"1879437","DOI":"10.1155\/2017\/1879437","volume":"2017","author":"H Yu","year":"2017","unstructured":"Yu H, Liu X, Zhong Y (2017) The Effect of Osteopontin on Microglia. Biomed Res Int 2017:1879437","journal-title":"Biomed Res Int"},{"key":"4767_CR27","doi-asserted-by":"publisher","first-page":"757515","DOI":"10.3389\/fnmol.2021.757515","volume":"14","author":"PP Guan","year":"2021","unstructured":"Guan PP et al (2021) Calcium Ions Aggravate Alzheimer\u2019s Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits. Front Mol Neurosci 14:757515","journal-title":"Front Mol Neurosci"},{"key":"4767_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fnins.2018.00523","volume":"12","author":"M Verma","year":"2018","unstructured":"Verma M, Wills Z, Chu CT (2018) Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson\u2019s and Other Neurodegenerative Diseases. Front Neurosci 12:523","journal-title":"Front Neurosci"},{"key":"4767_CR29","doi-asserted-by":"crossref","unstructured":"Ilbeyi A, Incecayir T (2009) Pharmacokinetic Modelling of Lamotrigine from Plasma Concentrations in Healthy Volunteers. J Bioanalysis Biomed, 01","DOI":"10.4172\/1948-593X.1000009"},{"key":"4767_CR30","doi-asserted-by":"publisher","first-page":"1207280","DOI":"10.3389\/fphys.2023.1207280","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T et al (2023) The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Physiol 14:1207280","journal-title":"Front Physiol"},{"key":"4767_CR31","doi-asserted-by":"publisher","first-page":"857229","DOI":"10.3389\/fncel.2022.857229","volume":"16","author":"E Dzyubenko","year":"2022","unstructured":"Dzyubenko E, Hermann DM, Wang J (2022) Editorial: Perspectives of Astrocytes in Neurodevelopmental and Neurodegenerative Diseases: From Mechanistic Studies to Therapeutic Applications. Front Cell Neurosci 16:857229","journal-title":"Front Cell Neurosci"},{"key":"4767_CR32","doi-asserted-by":"publisher","first-page":"889939","DOI":"10.3389\/fncel.2022.889939","volume":"16","author":"M Sobolczyk","year":"2022","unstructured":"Sobolczyk M, Boczek T (2022) Astrocytic Calcium and cAMP in Neurodegenerative Diseases. Front Cell Neurosci 16:889939","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"4767_CR33","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.4103\/1673-5374.373664","volume":"18","author":"R Gopalakrishna","year":"2023","unstructured":"Gopalakrishna R et al (2023) Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer\u2019s disease prevention. Neural Regen Res 18(12):2675\u20132676","journal-title":"Neural Regen Res"},{"issue":"20","key":"4767_CR34","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.1073\/pnas.172504199","volume":"99","author":"OV Vitolo","year":"2002","unstructured":"Vitolo OV et al (2002) Amyloid \u03b2-peptide inhibition of the PKA\/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci 99(20):13217\u201313221","journal-title":"Proc Natl Acad Sci"},{"issue":"49","key":"4767_CR35","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1523\/JNEUROSCI.2535-21.2022","volume":"42","author":"EE Esvald","year":"2022","unstructured":"Esvald EE et al (2022) Differential Regulation of the BDNF Gene in Cortical and Hippocampal Neurons. J Neurosci 42(49):9110\u20139128","journal-title":"J Neurosci"},{"key":"4767_CR36","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs KA et al (2007) TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proceedings of the National Academy of Sciences, 104(11): pp. 4700\u20134705","DOI":"10.1073\/pnas.0607524104"},{"issue":"7","key":"4767_CR37","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.0367-19.2019","volume":"40","author":"EE Esvald","year":"2020","unstructured":"Esvald EE et al (2020) CREB Family Transcription Factors Are Major Mediators of BDNF Transcriptional Autoregulation in Cortical Neurons. J Neurosci 40(7):1405\u20131426","journal-title":"J Neurosci"},{"issue":"6","key":"4767_CR38","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11(6):1164\u20131178","journal-title":"Arch Med Sci"},{"key":"4767_CR39","doi-asserted-by":"publisher","first-page":"1167747","DOI":"10.3389\/fnmol.2023.1167747","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J (2023) Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectives. Front Mol Neurosci 16:1167747","journal-title":"Front Mol Neurosci"},{"key":"4767_CR40","doi-asserted-by":"crossref","unstructured":"Ahmed MB et al (2022) cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach. Cells, 11(13)","DOI":"10.3390\/cells11132020"},{"issue":"18","key":"4767_CR41","doi-asserted-by":"publisher","first-page":"14672","DOI":"10.1074\/jbc.M111.335091","volume":"287","author":"JM Steichen","year":"2012","unstructured":"Steichen JM et al (2012) Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J Biol Chem 287(18):14672\u201314680","journal-title":"J Biol Chem"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04767-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:24:40Z","timestamp":1782707080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4767"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04767-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Guangzhou Myers Biotechnology Co., Ltd (IACUC-MIS2023050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"149"}}